卵丘复合体有利于卵胞浆内单精子注射中精子的生理性选择
该前瞻性同胞卵母细胞研究纳入60对接受ICSI的夫妇(女性≤38岁,至少获取6个MII卵母细胞),将857个MII卵母细胞分为COC-ICSI组(429个,经卵丘复合体选择精子)和常规ICSI对照组(428个)。COC-ICSI组受精率(85.31% vs 74.77%)、囊胚形成率(64.90% vs 53.50%)、第5天囊胚形成率(46.52% vs 38.85%)、优质囊胚率(38.72% vs 24.20%)、可用囊胚形成率(62.12% vs 46.82%)及卵母细胞利用率(51.98% vs 34.35%)均显著高于对照组;第3天卵裂率和优质胚胎率两组无统计学差异。结论认为COCs用于ICSI精子选择似乎有效,可统计学显著改善囊胚发育和质量。
要点
- COC-ICSI组受精率85.31% vs 常规ICSI组74.77%,显著提高。
- COC-ICSI组囊胚形成率64.90% vs 对照组53.50%,优质囊胚率38.72% vs 24.20%。
- COC-ICSI组卵母细胞利用率51.98% vs 对照组34.35%,显著改善。
核心结论
- 使用卵丘复合体为ICSI选择精子似乎有效,并统计学显著改善了囊胚发育和质量。
- COC-ICSI组累积胚胎种植率64.29%略高于对照组53.85%,但无统计学差异。
研究设计与样本
- 前瞻性同胞卵母细胞研究,纳入2016年接受ICSI的60对夫妇,女性年龄≤38岁且至少获取6个MII卵母细胞。
- 857个MII卵母细胞中429个分配至研究组(COC-ICSI),428个分配至对照组(常规ICSI)。
主要发现
- COC-ICSI组受精率85.31% vs 常规ICSI组74.77%,显著更高。
- 第3天卵裂率和优质胚胎率两组无统计学差异。
- COC-ICSI组囊胚形成率64.90% vs 对照组53.50%,第5天囊胚形成率46.52% vs 38.85%,优质囊胚率38.72% vs 24.20%,可用囊胚形成率62.12% vs 46.82%,均显著改善。
- COC-ICSI组卵母细胞利用率51.98% vs 对照组34.35%,显著提高。
- 常规IVF与COC-ICSI组在受精率、第3天优质胚胎率、可用囊胚率、优质囊胚率及第5天可用囊胚率方面相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the effectiveness of cumulus oophorus complexes (COCs) in the physiologic selection of spermatozoa for intracytoplasmic sperm injection (ICSI). DESIGN: A prospective sibling oocytes study. SETTING: Center of reproductive medicine. PATIENT(S): Couples undergoing ICSI during 2016, females aged ≤38 years, and at least six metaphase II (MII) oocytes retrieved. Sixty patients were included in the study. Of 857 MII oocytes, 429 were allocated to the study group and were injected with the sperm selected via COCs; 428 MII oocytes were allocated as controls (C) and fertilized by conventional ICSI. INTERVENTION(S): In the study group, ICSI was performed with spermatozoa that traversed the COCs in vitro. MAIN OUTCOMES MEASURE(S): Blastocyst/top blastocyst formation rate, fertilization rate, and oocyte utilization rate. RESULT(S): Oocytes injected with COC-selected spermatozoa had a significantly higher fertilization rate than the conventional ICSI group (85.31% vs. 74.77%). There were no statistically differences in cleavage and top embryo rate on day 3 between the COC-ICSI and C-ICSI groups. However, with day 5 or 6 embryos, compared with conventional ICSI, COC-ICSI significantly improved blastocyst formation rate (64.90% vs. 53.50%), blastocyst formation rate at day 5 (46.52% vs. 38.85%), top blastocyst rate (38.72% vs. 24.20%), and the usable blastocysts formation rate (62.12% vs. 46.82%). The oocyte utilization rate was improved greatly in the COC-ICSI group compared with the C-ICSI group (51.98% vs. 34.35%). Furthermore, the fertilization rate, top embryo rate on day 3, usable blastocyst rate, top blastocyst rate, and day 5 usable blastocysts rate were similar between the conventional IVF and COC-ICSI groups. Single-blastocyst transfer was performed in 82 cycles, including 44 fresh cycles and 38 frozen-thawed cycles. The cumulative embryo implantation rate in the COC-ICSI group was 64.29%, slightly higher than in the C-ICSI group (53.85%), but there was no statistical difference. CONCLUSION(S): The use of COCs to select spermatozoa for ICSI appears to be effective and led to a statistically significant improvement in blastocyst development and quality.
引用
- Wang C, Feng G, Shu J, et al. Cumulus oophorus complexes favor physiologic selection of spermatozoa for intracytoplasmic sperm injection. Fertil Steril. 2018. PMID: 29605408. doi:10.1016/j.fertnstert.2017.12.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。